Navigation Links
Research and Markets - Global Antiviral Drugs Market to Grow at a CAGR of 9.48%, 2017-2021 with Bristol-Myers Squibb, F. Hoffmann-La Roche, Gilead Sciences & GlaxoSmithKline Leading the Market
Date:4/18/2017

DUBLIN, April 18, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Antiviral Drugs Market 2017-2021" report to their offering.

The global antiviral drugs market to grow at a CAGR of 9.48% during the period 2017-2021.

The report, Global Antiviral Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

The latest trend gaining momentum in the market is technological advancements. The new hybridoma technique is a novel approach toward the development of monoclonal antibodies, which are selective in nature. This technique will not only have a positive impact against viral diseases but also decrease the cost of the overall treatment. It can be expected that antiviral agents, which were above $100 and could be used to control an epidemic effectively, can now be produced at 1% of its original cost.

According to the report, one of the major drivers for this market is stockpiling by public healthcare agencies. The CDC estimates that government organizations such as the WHO are also taking initiatives to secure public health during future outbreak of viral diseases by increasing the antiviral drugs stock. The CDC manages the Strategic National Stockpile, which includes storage of bulk quantities of antiviral medications for public health emergencies.

Key vendors

  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche
  • Gilead Sciences
  • GlaxoSmithKline

Other prominent vendors

  • AbbVie
  • Johnson & Johnson
  • Merck
  • Novartis

Key Topics Covered:

PART 01: Executive summary

PART 02: Research Methodology

PART 03: Introduction

PART 04: Disease Overview

PART 05: Market landscape

PART 06: Pipeline analysis

PART 07: Market segmentation by therapies

PART 08: Market segmentation by MOA

PART 09: Geographical segmentation

PART 10: Decision framework

PART 11: Drivers and challenges

PART 12: Market trends

PART 13: Competitive Landscape

PART 14: Key vendor analysis

PART 15: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/djspnx/global_antiviral

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com 

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 



To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/research-and-markets---global-antiviral-drugs-market-to-grow-at-a-cagr-of-948-2017-2021-with-bristol-myers-squibb-f-hoffmann-la-roche-gilead-sciences--glaxosmithkline-leading-the-market-300440814.html


'/>"/>
SOURCE Research and Markets
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Global Information Online Market Research Portal Provides Complimentary Sample Service for Customers to Preview Reports by Global Industry Analysts
2. Edgemont Capital Completes Sale Of Vince & Associates Clinical Research
3. Research Team Publishes New Methods for Synthetic Generation of Influenza Vaccines
4. Sony Biotechnology Inc.s New Technology for Science Provides Researchers Results in Color
5. Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR
6. Research-based Pharmaceutical Industry Launches Do You Mind? Campaign to Fight Mental and Neurological Disorders
7. Lupus Research Institute Hosts First International Conference to Advance New Treatments for Lupus Nephritis
8. Clinical Team Researching the Impact of the EarlySense System Wins Best Novel Idea Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference
9. International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma
10. Cempra Awarded $58 Million Contract to Develop Antibiotic for Pediatric Use and Biodefense by Biomedical Advanced Research and Development Authority (BARDA)
11. Alzheimer Market: Drugs, Therapeutics & Diagnostics Research Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... to the Centers for Disease Control and Prevention (CDC), influenza vaccination ... is helping communities across Massachusetts , Connecticut ... flu shots through the end of the month. *Some exclusions ... ... shot is by the end of October, according to the Centers for ...
(Date:10/2/2017)... , Oct. 2, 2017 Diplomat Pharmacy, ... 8th Day Software and Consulting, LLC , and named ... 8th Day Software, based in Tennessee , ... 8th Day expands EnvoyHealth,s service offerings for health care ... "In an interoperable ...
(Date:10/2/2017)... 2017  AllianceRx Walgreens Prime, the combined central specialty ... pharmacy benefit manager Prime Therapeutics LLC (Prime), today officially ... the unveiling of new signage at its headquarters in ... at a few other company-owned facilities across the country. ... some of whom will begin to see the AllianceRx ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the Mission ... lost souls in the Philippines. “The Journey: From the Mountains to the Mission Field” ... the Bible. She has taught all ages and currently teaches a class of ladies ...
(Date:10/12/2017)... , ... October 12, 2017 , ... Planet Fitness, one ... U.S., announced today its plans to open a flagship location in Covington, LA at ... former Rooms To Go store next to Office Depot in the Holiday Square shopping ...
(Date:10/12/2017)... ... , ... Asante, a nationally recognized health system in southern ... home health joint venture through an agreement, effective October 1, 2017, to create ... health company with Asante, delivering clinically integrated care, for the past eight years. ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... property taxes a year. In some states—like New York, New Jersey, Massachusetts, Texas, ... many overseas retirement havens have extremely low property-tax rates, which contributes to the ...
Breaking Medicine News(10 mins):